Pfizer Inc (PFE)
Gross profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Gross profit | US$ in thousands | 47,207,000 | 28,809,000 | 65,986,000 | 50,467,000 | 33,216,000 |
| Revenue | US$ in thousands | 63,627,000 | 58,496,000 | 100,330,000 | 81,288,000 | 41,908,000 |
| Gross profit margin | 74.19% | 49.25% | 65.77% | 62.08% | 79.26% |
December 31, 2024 calculation
Gross profit margin = Gross profit ÷ Revenue
= $47,207,000K ÷ $63,627,000K
= 74.19%
The gross profit margin of Pfizer Inc has displayed fluctuations over the past five years. Starting at 79.26% as of December 31, 2020, the margin decreased to 62.08% by December 31, 2021. However, there was a slight improvement by December 31, 2022, with the margin increasing to 65.77%. Subsequently, by December 31, 2023, there was a significant decrease in the gross profit margin to 49.25%. The most recent data point as of December 31, 2024, shows a notable recovery, with the margin rising to 74.19%. These fluctuations may indicate changes in Pfizer's pricing strategy, cost structure, or sales mix over the years, impacting the company's profitability at the gross level.
Peer comparison
Dec 31, 2024